NYSE · VEC
Industrials · Aerospace & Defense
$32.84
Up+$0.21 (+0.64%)
Updated Aug 14, 2026, 9:19 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
VEC does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning VEC.
VEC research
Company profile and research snapshot.
Vertex Aerospace Services Holding Corp. was incorporated in 2018 and is based in Delaware, United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 1, 2022 | Truist Securities | Buy | — |
| Mar 18, 2022 | Stifel | Hold | — |
| Mar 5, 2020 | B. Riley FBR | Buy | — |
| Jan 6, 2020 | Stifel | Buy | — |
| Nov 6, 2019 | B. Riley | Buy | — |
No generated briefing is available yet.
Zacks Investment Research · May 10, 2022
Vectrus (VEC) delivered earnings and revenue surprises of 23.17% and 7.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · May 3, 2022
Vectrus (VEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Benzinga · Apr 1, 2022
Upgrades For Banco Santander SA (NYSE:SAN), Credit Suisse upgraded the previous rating of Neutral to Outperform. Banco Santander earned $0.14 in the fourth quarter, compared to $0.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.38 and a 52-week-low of $2.77. Banco Santander closed at $3.38 at the end of the last trading period. Goldman Sachs upgraded the previous rating for Comerica Inc (NYSE:CMA) from Sell to Neutral. In the fourth quarter, Comerica showed an EPS of $1.66, compared to $1.49 from the year-ago quarter. At the moment, the stock has a 52-week-high of $102.09 and a 52-week-low of $63.07. Comerica closed at $90.43 at the end of the last trading period. According to Stifel, the prior rating for Centennial Resource Development Inc (NASDAQ:CDEV) was changed from Hold to Buy. For the fourth quarter, Centennial Resource Dev had an EPS of $0.51, compared to year-ago quarter EPS of $0.32. The current stock performance of Centennial Resource Dev shows a 52-week-high of $9.30 and a 52-week-low of $3.69. Moreover, at the end of the last trading period, the closing price was at $8.07. According to JP Morgan, the prior rating for Comerica Inc (NYSE:CMA) was changed from Neutral to Overweight. Comerica earned $1.66 in the fourth quarter, compared to $1.49 in the year-ago quarter. The current stock performance of Comerica shows a 52-week-high of $102.09 and a 52-week-low of $63.07. Moreover, at the end of the last trading period, the closing price was at $90.43. According to JP Morgan, the prior rating for Vertiv Holdings Co (NYSE:VRT) was changed from Neutral to Overweight. For the fourth quarter, Vertiv Holdings had an EPS of $0.04, compared to year-ago quarter EPS of $0.33. At the moment, the stock has a 52-week-high of $28.80 and a 52-week-low of $9.59. Vertiv Holdings closed at $14.00 at the end of the last trading period. According to Credit Suisse, the prior rating for Tellurian Inc (AMEX:TELL) was changed from Neutral to Outperform. Tellurian earned $0.09 in the fourth quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $5.94 and a 52-week-low of $1.62. Tellurian closed at $5.30 at the end of the last trading period. See all analyst ratings upgrades. Downgrades According to JonesTrading, the prior rating for Silverback Therapeutics Inc (NASDAQ:SBTX) was changed from Buy to Hold. In the fourth quarter, Silverback Therapeutics showed an EPS of $0.67, compared to $1.37 from the year-ago quarter. The stock has a 52-week-high of $46.55 and a 52-week-low of $3.36. At the end of the last trading period, Silverback Therapeutics closed at $3.51. Baird downgraded the previous rating for Walgreens Boots Alliance Inc (NASDAQ:WBA) from Outperform to Neutral. For the second quarter, Walgreens Boots Alliance had an EPS of $1.59, compared to year-ago quarter EPS of $1.26. The stock has a 52-week-high of $57.05 and a 52-week-low of $43.62. At the end of the last trading period, Walgreens Boots Alliance closed at $44.77. According to Truist Securities, the prior rating for Science Applications International Corp (NYSE:SAIC) was changed from Buy to Hold. In the fourth quarter, Science Applications Intl showed an EPS of $1.50, compared to $1.67 from the year-ago quarter. The stock has a 52-week-high of $96.50 and a 52-week-low of $78.10. At the end of the last trading period, Science Applications Intl closed at $92.17. For Qorvo Inc (NASDAQ:QRVO), KGI Securities downgraded the previous rating of Outperform to Neutral. For the third quarter, Qorvo had an EPS of $2.98, compared to year-ago quarter EPS of $3.08. The current stock performance of Qorvo shows a 52-week-high of $201.68 and a 52-week-low of $117.03. Moreover, at the end of the last trading period, the closing price was at $124.10. According to SMBC Nikko, the prior rating for Orchard Therapeutics PLC (NASDAQ:ORTX) was changed from Outperform to Neutral. Orchard Therapeutics earned $0.29 in the fourth quarter, compared to $0.34 in the year-ago quarter. At the moment, the stock has a 52-week-high of $7.47 and a 52-week-low of $0.68. Orchard Therapeutics closed at $0.71 at the end of the last trading period. According to SVB Leerink, the prior rating for Silverback Therapeutics Inc (NASDAQ:SBTX) was changed from Outperform to Market Perform. In the fourth quarter, Silverback Therapeutics showed an EPS of $0.67, compared to $1.37 from the year-ago quarter. The current stock performance of Silverback Therapeutics shows a 52-week-high of $46.55 and a 52-week-low of $3.36. Moreover, at the end of the last trading period, the closing price was at $3.51. According to Barclays, the prior ...Full story available on Benzinga.com
Benzinga · Mar 18, 2022
Stifel analyst Bert Subin resumed coverage on several companies in the U.S. Government Services space, citing rising geopolitical tensions, the public perception of threats, and his view that the battlespace is becoming increasingly digital. The analyst resumed coverage of Vectrus Inc (NYSE: VEC) with a Hold rating and a price target of $42, implying an upside of 13%. Subin states ...Full story available on Benzinga.com
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning VEC.
No results
No recent SID articles mention VEC.
